Latest news
{{'2026-02-20T12:02:49Z' | dateFormatFilter}}
Novo Nordisk A/S: Notice for the Annual General Meeting of Novo Nordisk A/S
{{'2026-02-17T13:58:25Z' | dateFormatFilter}}
Novo Nordisk A/S: The European Commission approves more effective dose of injectable Wegovy® for adults with obesity; clinical study showed people lost about 21% of their body weight on average
{{'2026-02-09T11:59:38Z' | dateFormatFilter}}
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
Investors
Share price
{{priceData.date}} {{priceData.time}}
{{priceData.currentPrice}}
{{priceData.currency}}
Go to stock watch
{{priceData.change}} {{priceData.currency}}
